Suchergebnisse - "Walker, Gennyne"

PubPharm (36)

1

Efzofitimod for the Treatment of Pulmonary Sarcoidosis

enthalten in: Chest | 2023

von Culver, D. | Aryal, S. | Barney, J. | +11

2

Efzofitimod : a novel anti-inflammatory agent for sarcoidosis

enthalten in: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG | 2023

von Baughman, R. | Niranjan, V. | Walker, G. | +12

3

Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis

enthalten in: Frontiers in pharmacology | 2023

von Walker, G. | Adams, R. | Guy, L. | +6

4

Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy

enthalten in: Muscle & nerve | 2022

von Gidaro, T. | Gasnier, E. | Annoussamy, M. | +9

5

Home‐based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy

enthalten in: Muscle & Nerve | 2022

von Gidaro, T. | Gasnier, E. | Annoussamy, M. | +9

6

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI) : a multicentre, randomised, double-blind, placebo-controlled trial

enthalten in: Lancet (London, England) | 2016

von Weisz, G. | Généreux, P. | Iñiguez, A. | +111

CommentIn: Lancet. 2016 Jan 9;387(10014):100-2. - PMID 26474812

7

Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome : Observations From the MERLIN-TIMI 36 Trial

enthalten in: Clinical cardiology | 2015

von Gutierrez, J. | Karwatowska-Prokopczuk, E. | Murphy, S. | +5

8

Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention : design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial

enthalten in: American heart journal | 2013

von Weisz, G. | Farzaneh-Far, R. | Ben-Yehuda, O. | +10

9

Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post–Percutaneous Coronary Intervention (RIVER-PCI) trial

enthalten in: American heart journal | 2013

von Weisz, G. | Farzaneh-Far, R. | Ben-Yehuda, O. | +10

10

Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension

enthalten in: Pulmonary circulation | 2013

von Morrell, N. | Archer, S. | Defelice, A. | +10